Vanda Pharmaceuticals Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Washington, DC
VNDA chart
What traders are saying about $VNDA
Latest postsVanda Pharmaceuticals Inc. news
- Form SCHEDULE 13G Vanda Pharmaceuticals Filed by: STATE STREET CORP
StreetInsider ·
- State Street reports 3.01 million shares in a passive Vanda Pharmaceuticals (VNDA) stake.
Stock Titan ·
- Vanda Pharmaceuticals Stock Price Forecast. Should You Buy VNDA?
StockInvest.us ·
- Vanda Pharmaceuticals Inc (VM4.DU) Seasonal returns chart - Yahoo Finance
Yahoo Finance Singapore ·
- Vanda Pharmaceuticals director Charles Duncan buys $38,093 in stock By Investing.com
Investing.com Nigeria ·
- Vanda Pharmaceuticals director Charles Duncan buys $38,093 in stock
Investing.com ·
- Form 4 Vanda Pharmaceuticals Inc: Charles Cliff Duncan (Director) For: 3 November
Investing.com UK ·
- Vanda Pharmaceuticals Inc. News — LSE:0LKB
TradingView ·
- Vanda Pharmaceuticals Inc. News — BOATS:VNDA
TradingView ·
- Vanda Pharmaceuticals to present at multiple he...
Pluang ·
- Vanda Pharmaceuticals Announces Participation at November 2026 Investor Conferences
Yahoo Finance ·
- Two Vanda conference chats may be watched live in November
Stock Titan ·
Vanda Pharmaceuticals Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $216.1M | $198.8M | $192.6M | $254.4M |
| Net income | -$220.5M | -$18.9M | $2.5M | $6.3M |
| Diluted EPS | $-3.74 | $-0.33 | $0.04 | $0.11 |
| Total assets (year end) | $488.9M | $656.2M | $648.4M | $634.2M |
| Cash and equivalents (year end) | $84.9M | $102.3M | $135.8M | $135.0M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Vanda Pharmaceuticals Inc.
- Ticker
- VNDA (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Washington, DC
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1347178
Frequently asked questions
What exchange is Vanda Pharmaceuticals Inc. listed on?
Vanda Pharmaceuticals Inc. trades on the Nasdaq under the ticker symbol VNDA.
What industry is Vanda Pharmaceuticals Inc. in?
Vanda Pharmaceuticals Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Vanda Pharmaceuticals Inc. headquartered?
Vanda Pharmaceuticals Inc.'s business address on file with the SEC is in Washington, DC.
When does Vanda Pharmaceuticals Inc.'s fiscal year end?
Vanda Pharmaceuticals Inc.'s fiscal year ends on December 31.
How much revenue did Vanda Pharmaceuticals Inc. report?
Vanda Pharmaceuticals Inc. reported $216.1M in revenue for calendar year 2025, according to its SEC filings.